Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

dosimetry

  • Prostate-Specific Membrane Antigen Radioligand Therapy Using <sup>177</sup>Lu-PSMA I&amp;T and <sup>177</sup>Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry
    You have access
    Prostate-Specific Membrane Antigen Radioligand Therapy Using 177Lu-PSMA I&T and 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry
    Christiane Schuchardt, Jingjing Zhang, Harshad R. Kulkarni, Xiaoyuan Chen, Dirk Müller and Richard P. Baum
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1199-1207; DOI: https://doi.org/10.2967/jnumed.121.262713
  • Biodistribution and Radiation Dosimetry of Intraperitoneally Administered <sup>124</sup>I-Omburtamab in Patients with Desmoplastic Small Round Cell Tumors
    You have access
    Biodistribution and Radiation Dosimetry of Intraperitoneally Administered 124I-Omburtamab in Patients with Desmoplastic Small Round Cell Tumors
    Milan Grkovski, Shakeel Modak, Pat B. Zanzonico, Jorge A. Carrasquillo, Steven M. Larson, John L. Humm and Neeta Pandit-Taskar
    Journal of Nuclear Medicine July 1, 2022, 63 (7) 1094-1100; DOI: https://doi.org/10.2967/jnumed.121.262793
  • Pretherapeutic Comparative Dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA I&amp;T in Patients with Metastatic Castration-Resistant Prostate Cancer
    You have access
    Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
    Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, Robert Tauber, Jakob Allmann, Lisa Steinhelfer, Isabel Rauscher, Alexander Wurzer, Hans-Jürgen Wester, Wolfgang A. Weber, Calogero d’Alessandria and Matthias Eiber
    Journal of Nuclear Medicine June 1, 2022, 63 (6) 833-839; DOI: https://doi.org/10.2967/jnumed.121.262671
  • 
    Biokinetics and Dosimetry of <sup>177</sup>Lu-Pentixather
    You have access
    Biokinetics and Dosimetry of 177Lu-Pentixather
    Heribert Hänscheid, Andreas Schirbel, Philipp Hartrampf, Sabrina Kraus, Rudolf A. Werner, Hermann Einsele, Hans-Jürgen Wester, Michael Lassmann, Martin Kortüm and Andreas K. Buck
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 754-760; DOI: https://doi.org/10.2967/jnumed.121.262295
  • You have access
    A pipeline for automated voxel dosimetry: application in patients with multi-SPECT/CT imaging following 177Lu peptide receptor radionuclide therapy
    Yuni K. Dewaraja, David M Mirando, Avery Peterson, Jeremy Niedbala, John D Millet, Justin K Mikell, Kirk Frey, Ka Kit Wong, Scott Wilderman and Aaron S Nelson
    Journal of Nuclear Medicine April 14, 2022, jnumed.121.263738; DOI: https://doi.org/10.2967/jnumed.121.263738
  • Open Access
    MIRD Pamphlet No. 27: MIRDcell V3, a revised software tool for multicellular dosimetry and bioeffect modeling
    Sumudu Katugampola, Jianchao Wang, Alex Rosen and Roger W. Howell
    Journal of Nuclear Medicine February 10, 2022, jnumed.121.263253; DOI: https://doi.org/10.2967/jnumed.121.263253
  • <sup>131</sup>I-GD2-ch14.18 Scintigraphy to Evaluate Option for Radioimmunotherapy in Patients with Advanced Tumors
    You have access
    131I-GD2-ch14.18 Scintigraphy to Evaluate Option for Radioimmunotherapy in Patients with Advanced Tumors
    Ying Zhang, Juergen Kupferschlaeger, Peter Lang, Gerald Reischl, Rupert J. Handgretinger, Christian la Fougère and Helmut Dittmann
    Journal of Nuclear Medicine February 1, 2022, 63 (2) 205-211; DOI: https://doi.org/10.2967/jnumed.120.261854
  • You have access
    Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns
    George Sgouros, Yuni K. Dewaraja, Freddy Escorcia, Stephen A. Graves, Thomas A. Hope, Amir Iravani, Neeta Pandit-Taskar, Babak Saboury, Sara St. James and Pat B. Zanzonico
    Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 12S-22S; DOI: https://doi.org/10.2967/jnumed.121.262750
  • You have access
    An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 1: Design and Early Results of the SNMMI Dosimetry Challenge
    Carlos Uribe, Avery Peterson, Benjamin Van, Roberto Fedrigo, Jake Carlson, John Sunderland, Eric Frey and Yuni K Dewaraja
    Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 36S-47S; DOI: https://doi.org/10.2967/jnumed.121.262748
  • You have access
    Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources
    Jacek Capala, Stephen A. Graves, Aaron Scott, George Sgouros, Sara St. James, Pat Zanzonico and Brian E. Zimmerman
    Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 3S-11S; DOI: https://doi.org/10.2967/jnumed.121.262749

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 13
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire